Literature DB >> 12099898

Effects of intralaminar thalamic nuclei lesion on glutamic acid decarboxylase (GAD65 and GAD67) and cytochrome oxidase subunit I mRNA expression in the basal ganglia of the rat.

Jean-Jacques Bacci1, Lydia Kerkerian-Le Goff, Pascal Salin.   

Abstract

This study investigated the influence of thalamic inputs on neuronal metabolic activity in the rat basal ganglia. By means of in situ hybridization histochemistry, we examined the consequences of ibotenate-induced unilateral lesion of intralaminar thalamic nuclei on mRNA expression of cytochrome oxidase subunit-I (CoI) in the striatum and the subthalamic nucleus (STN) and of the two isoforms of glutamate decarboxylase (GAD65 and GAD67) in the striatum, globus pallidus (GP), entopeduncular nucleus (EP) and substantia nigra pars reticulata (SNr). In the striatum, GAD67 mRNA expression decreased selectively in the rostral part of the structure at 5 and 12 days postlesion (approximately -30%), whereas, GAD65 mRNA levels was downregulated only in the caudal striatum at 12 days (-29%). In both the striatum and STN, CoI mRNA expression decreased ipsilaterally at 5 and bilaterally at 12 days. In GP, GAD67 and GAD65 mRNA expression decreased ipsilaterally at 5 (-20% and -26%) and 12 days (-23% and -36%). In EP, selective bilateral decreases in GAD67 mRNA expression were found at 5 and 12 days (-50% and -40%). Conversely, in SNr, only GAD65 mRNA expression was reduced bilaterally at both time points. These data show that the thalamus exerts a widespread excitatory influence on the basal ganglia network that cannot be accounted for solely by its known direct connections. Given the recent data showing that intralaminar thalamic nuclei are a major nondopaminergic site of neurodegeneration in Parkinson's disease, these results may have a critical bearing on understanding the cellular basis of basal ganglia dysfunction in parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12099898     DOI: 10.1046/j.1460-9568.2002.02039.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  6 in total

1.  Is the loss of thalamostriatal neurons protective in parkinsonism?

Authors:  Sheila V Kusnoor; E Chris Muly; James I Morgan; Ariel Y Deutch
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

2.  An accurate method for the quantification of cytochrome C oxidase in tissue sections.

Authors:  Miguel Melendez-Ferro; Matthew W Rice; Rosalinda C Roberts; Emma Perez-Costas
Journal:  J Neurosci Methods       Date:  2013-01-30       Impact factor: 2.390

3.  Role of external pallidal segment in primate parkinsonism: comparison of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism and lesions of the external pallidal segment.

Authors:  Jesus Soares; Michele A Kliem; Ranjita Betarbet; J Timothy Greenamyre; Bryan Yamamoto; Thomas Wichmann
Journal:  J Neurosci       Date:  2004-07-21       Impact factor: 6.167

4.  Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice.

Authors:  Y P Deng; T Wong; C Bricker-Anthony; B Deng; A Reiner
Journal:  Neurobiol Dis       Date:  2013-08-19       Impact factor: 5.996

5.  Thalamic degeneration in MPTP-treated Parkinsonian monkeys: impact upon glutamatergic innervation of striatal cholinergic interneurons.

Authors:  Rosa M Villalba; Jean-Francois Pare; Solah Lee; Sol Lee; Yoland Smith
Journal:  Brain Struct Funct       Date:  2019-11-02       Impact factor: 3.270

6.  Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington's disease.

Authors:  Yun-Ping Deng; Ting Wong; Jim Y Wan; Anton Reiner
Journal:  Front Syst Neurosci       Date:  2014-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.